The Great Glaucoma Debate: Challenging and controversial topics on Glaucoma
Glaucoma management has advanced significantly, yet remains a field marked by ongoing controversy. Despite progress in imaging, medications, and surgery, many routine clinical decisions continue to be debated, directly impacting patient outcomes and quality of life. The choice between Selective Laser Trabeculoplasty (SLT) and topical medications challenges traditional first-line therapy, balancing compliance with long-term efficacy. In angle-closure disease, YAG peripheral iridotomy is being reconsidered against early lens extraction, questioning established norms. Similarly, the rise of Minimally Invasive Glaucoma Surgery (MIGS) prompts comparison with trabeculectomy, weighing safety against effectiveness. Finally, while retinal nerve fiber layer (RNFL) analysis is central to diagnosis and monitoring, its interpretation remains complex. These debates highlight the need for individualized, evidence-based decision-making in glaucoma care.
working as head of glaucoma department for the past 22 years. Did glaucoma fellowship from a reputed institute. Trained in trabs, MIGS and GDDs from reputed institutes. A high volume surgeon practicing phacoemulsification and glaucoma surgeries, conducting long term fellowship program in glaucoma and training fellows for 7 years. Also phacotrainer. Have conducted many surgical workshops on glaucoma. Have conducted various ICs on glaucoma and phaco. presented papers in national and international glaucoma forums. Winner of a glaucoma research paper in state and have national publications.